BRUCE DAVID LEVY, MD
Osteopathic Medicine in Boston, MA
License number
Massachusetts 72593
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
2
75 Brigham & WOMEN'S HOSPITAL PULMONARY DIVISION, Boston, MA 02115
111 Cypress St, Brookline, MA 02445
111 Cypress St, Brookline, MA 02445
Phone
(617) 732-7420
(857) 307-0896
(857) 307-0896
Personal information
See more information about BRUCE DAVID LEVY at radaris.comName
Address
Phone
8 Sumac Ln, Sharon, MA 02067
90 Ter Heun Dr STE 300, Falmouth, MA 02540
84 Ridge Rd, Marshfield, MA 02050
15 Punch Bowl Dr, Falmouth, MA 02540
1957 Commonwealth Ave, Brighton, MA 02135
Professional information
Evp At Mattress Firm
Position:
EVP Real Estate and Construction at Mattress Firm
Location:
Boca Raton, Florida
Industry:
Retail
Work:
Mattress Firm
- Houston,Tx since 2008
-
EVP Real Estate and Construction
PETCO Animal Supplies, Inc.
- San Diego 2005 - 2008
-
SVP Real Estate and Construction
Gateway
- Sioux City and San Diego Jan 2003 - Dec 2005
-
SVP Real Estate and Construction
Tweeter Home Entertainment
- Boston,Ma Jan 2004 - Jan 2005
-
SVP Real Estate and Construction
Blockbuster
- Atlanta,Ga 2000 - 2003
-
VP Real Estate
Office Depot
- Boca Raton,FL 1997 - 2003
-
Director or real estate
Education:
University of Florida 1976 - 1980
Business, Accounting, marketing
Business, Accounting, marketing
Associate Professor Of Medicine At Brigham And Women's Hospital
Position:
Associate Professor of Medicine at Brigham and Women's Hospital
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Work:
Brigham and Women's Hospital
-
Associate Professor of Medicine
Education:
University of Pennsylvania School of Medicine 1984 - 1988
Bruce David Levy, Boston MA
Specialties:
Internal Medicine, Critical Care Medicine, Pulmonary Disease, Medical Oncology, Allergy, Critical Care Medicine
Work:
Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115
44 Binney St, Boston, MA 02115
Education:
University of Pennsylvania(1988)
Instrumented Metered-Dose Inhaler And Methods For Predicting Disease Exacerbations
US Patent:
8342172, Jan 1, 2013
Filed:
Feb 3, 2008
Appl. No.:
12/525540
Inventors:
Bruce D. Levy - West Roxbury MA, US
Michael S. Singer - Newton Centre MA, US
Michael S. Singer - Newton Centre MA, US
Assignee:
The Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
A61M 11/00
US Classification:
12820023, 12820014, 12820019
Abstract:
The present invention is directed to devices, systems, and methods for monitoring inhaled drug usage to predict when an acute attack or exacerbation of a disease, such as a respiratory disease, is imminent. Instrumented inhalers that use modular designs with standard components are disclosed, as are systems for monitoring the instrumented inhalers. Also disclosed are methods for determining whether or not a patient's inhaled drug usage pattern indicates that an acute attack or disease exacerbation is imminent, and notifying appropriate medical personnel of any usage patterns indicative of an attack or disease exacerbation. If such an attack or exacerbation is imminent, additional therapeutic agents may be dispensed to the patient or other interventions made.
Screening Methods For Presqualene Diphosphate Analogs
US Patent:
6066466, May 23, 2000
Filed:
Apr 6, 1998
Appl. No.:
9/055592
Inventors:
Charles N. Serhan - Wellesley MA
Bruce D. Levy - West Roxbury MA
Bruce D. Levy - West Roxbury MA
Assignee:
Brigham & Womens Hospital - Boston MA
International Classification:
C12Q 134
US Classification:
435 18
Abstract:
The present invention is directed to presqualene diphosphate (PSDP) analogs having an active region of natural PSDP and a metabolic transformation region resistant to rapid intracellular inactivation in vivo. For example, PSDP and its stable analogs can inhibit neutrophil signal transduction events in cellular activation that result in the generation of active oxygen species, regulation of leukocyte adherence, both homotypic (leukocyte-leukocyte) or heterotypic adherence with leukocytes and epithelial cells of mucosal origin or endothelial cells of vascular origin. These analogs can also be used to regulate leukocyte-dependent tissue injury.
Anti-Inflammatory Actions Of Neuroprotectin D1/Protectin D1 And It's Natural Stereoisomers
US Patent:
8273792, Sep 25, 2012
Filed:
Oct 3, 2006
Appl. No.:
12/089141
Inventors:
Charles N. Serhan - Needham MA, US
Nicos A. Petasis - Hacienda Heights CA, US
Bruce D. Levy - West Roxbury MA, US
Nicos A. Petasis - Hacienda Heights CA, US
Bruce D. Levy - West Roxbury MA, US
Assignee:
The Brigham and Women's Hospital, Inc. - Boston MA
The University of Southern California - Los Angeles CA
The University of Southern California - Los Angeles CA
International Classification:
A01N 37/06, C07C 57/00, C07C 69/73, C07C 59/00
US Classification:
514549, 514560, 554224, 560183, 562587
Abstract:
(Neuro)protectin D1 (1OR,17S-dihydroxy-docosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid) and 15,16-dehydro-PD1 and their derivatives are useful in the treatment of airway inflammation, especially asthma.
Anti-Inflammatory Actions Of Neuroprotectin D1/Protectin D1 And Its Natural Stereoisomers
US Patent:
2013015, Jun 13, 2013
Filed:
Sep 24, 2012
Appl. No.:
13/625865
Inventors:
Charles N. Serhan - Needham MA, US
Nicos A. Petasis - Hacienda Heights CA, US
Bruce D. Levy - West Roxbury MA, US
Nicos A. Petasis - Hacienda Heights CA, US
Bruce D. Levy - West Roxbury MA, US
International Classification:
A61K 31/202
US Classification:
514560, 554219
Abstract:
The invention describes novel isolated, purified, 10,17-dihydroxy-docoosahexaenoic acids, esters, derivatives and their preparation.
Method For Treating Airway Hyper-Responsiveness With Lipoxin Analogs
US Patent:
2012014, Jun 14, 2012
Filed:
Feb 21, 2012
Appl. No.:
13/401519
Inventors:
Charles N. Serhan - Needham MA, US
Bruce D. Levy - West Roxbury MA, US
Bruce D. Levy - West Roxbury MA, US
Assignee:
The Brigham and Women's Hospital - Boston MA
International Classification:
A61K 31/232, A61K 31/202, A61P 11/00, A61K 31/235
US Classification:
514543, 514549, 514529, 514560, 514559
Abstract:
The use of lipoxin analogs for the treatment or prevention of asthma and asthma related diseases is described. In particular, acetylenic lipoxin analogs are effective for the treatment and prevention of eosinophil recruitment involved with the inflammation processes associated with asthma, asthma like conditions, and lung injuries associated from airway inflammation or infection as brought about by leukocyte-mediated injury from within.
Lipoxins And Aspirin-Triggered Lipoxins And Their Stable Analogs In The Treatment Of Asthma And Inflammatory Airway Diseases
US Patent:
2008006, Mar 13, 2008
Filed:
Aug 13, 2007
Appl. No.:
11/837674
Inventors:
Charles Serhan - Needham MA, US
Bruce Levy - West Roxbury MA, US
Bruce Levy - West Roxbury MA, US
International Classification:
A61K 31/216, A61K 31/22, A61P 11/00, A61P 29/00
US Classification:
514532000, 514552000
Abstract:
The use of lipoxin analogs for the treatment or prevention of asthma and asthma related diseases is described. In particular, acetylenic lipoxin analogs are effective for the treatment and prevention of eosinophil recruitment involved with the inflammation processes associated with asthma, asthma like conditions, and lung injuries associated from airway inflammation or infection as brought about by leukocyte-mediated injury from within.
Inhalation Device And System For The Remote Monitoring Of Drug Administration
US Patent:
2005017, Aug 11, 2005
Filed:
Aug 18, 2004
Appl. No.:
11/037903
Inventors:
Michael Singer - Cambridge MA, US
Bruce Levy - West Roxbury MA, US
Bruce Levy - West Roxbury MA, US
International Classification:
A61M011/00
US Classification:
128200230, 128200140
Abstract:
The present invention is directed to a device for monitoring the usage of inhaled drugs by a patient. The device includes an inhaler, a use sensor, a microprocessor, a wireless transmitter and a battery compartment. These components allow information concerning drug usage to be transmitted to health care personnel that can evaluate the data to determine whether there are changes in drug usage characteristics that are indicative of an impending acute attack. The invention includes not only the device, but also the systems and methods in which the device is employed.